Hope Beyond Hype

Hope Beyond Hype - A comic about stem cells from discovery to therapy!

The story provides a realistic and accurate introduction to the complex process of developing best practice clinical stem cell-based treatments, in an interesting and engaging way. We believe it is important to engage people with our work and therefore hope the graphic story will be useful for public events, new patients and carers, patient advocacy groups, educationalists, public engagement practitioners and researchers.

Also available in 18 other languages! 

French, German, Italian, Polish, Spanish (select language at the top)

ArabicCatalanChineseCzechDutchFinnishGreekJapaneseMalayPortugueseRomanianSwedish and Turkish

Hope Beyond Hype: other formats

About this Project

The Hope Beyond Hype graphic story grew from the desire of OptiStem, a large European consortium of stem cell researchers, to go beyond just explaining the science of stem cells.  They wanted to depict the process they undertake as they try to move stem cell research on towards clinical trials and therapies.

Hope Beyond Hype - PDF35.46 MB Classroom Activity - Make your own comic260.64 KB Engagement Activity - Card Games about developing treatments3.75 MB Arabic Version27.67 MB Catalan Version29.26 MB Chinese Version15.34 MB Czech Version55.77 MB Dutch Version44.23 MB Finnish Version29.06 MB French Version41.23 MB German Version40.84 MB Greek Version23.17 MB Italian Version40.35 MB Japanese Version3.35 MB Malay Version21.42 MB Polish Version46.55 MB Portuguese Version28.4 MB Romanian Version57 MB Spanish Version41.04 MB Swedish Version29.29 MB Turkish Version28.98 MB


Written by Ken Macleod, with Jamie Hall, Edward Ross and Cathy Southworth. Illustrated by Edward Ross.

Optistem Logo

About OptiStem

OptiStem is a pan-European stem cell research project funded by the European Commission under FP7. It brought together scientists, companies and clinicians from 18 institutions across six countries.  During the course of the five year OptiStem project, members carried out four different clinical trials concerning muscular dystrophy, severe corneal injury in the eye and severe damage to the oral mucosa (inside of mouth).  OptiStem partnered with EuroStemCell to tell people about their work.